+
Home In-silico screening of bioactive compounds of Moringa oleifera as potential inhibitors targeting HIF-1α/VEGF/GLUT-1 pathway against breast cancer
Article
Licensed
Unlicensed Requires Authentication

In-silico screening of bioactive compounds of Moringa oleifera as potential inhibitors targeting HIF-1α/VEGF/GLUT-1 pathway against breast cancer

  • Neha Masarkar , Maynak Pal , Mithun Roy , Ashish K. Yadav , Bharati Pandya , Suryabhan Lokhande , Jagat R. Kanwar , Suman Kumar Ray and Sukhes Mukherjee EMAIL logo
Published/Copyright: July 22, 2024

Abstract

Objectives

Breast cancer is among the most heterogeneous and aggressive diseases and a foremost cause of death in women globally. Hypoxic activation of HIF-1α in breast cancers triggers the transcription of a battery of genes encoding proteins that facilitate tumor growth and metastasis and is correlated with a poor prognosis. Based on the reported cytotoxic and anti-cancer properties of Moringa oleifera (Mo), this study explores the inhibitory effect of bioactive compounds from M. oleifera and breast cancer target proteins HIF-1α, VEGF, and GLUT-1 in silico.

Methods

The X-ray crystallographic structures of HIF-1α, VEGF, and GLUT1 were sourced from the Protein Data Bank (PDB) and docked with 70 3D PubChem structures of bioactive compounds of M. oleifera using AutoDock Vina, and binding modes were analyzed using Discovery Studio. Five compounds with the highest binding energies were selected and further drug-likeness, oral bioavailability, ADME, and toxicity profiles were analyzed using SwissADME, ADMETSaR, and ADMETlab 3.0 web server.

Results

Out of the screened 70 bioactive compounds, the top five compounds with the best binding energies were identified namely Apigenin, Ellagic Acid, Isorhamnetin, Luteolin, and Myricetin with each receptor. Molecular docking results indicated that the ligands interact strongly with the target HIF-1α, VEGF, and GLUT-1 receptors through hydrogen bonds and hydrophobic interactions. These compounds showed favorable drug-like and pharmacokinetic properties, possessed no substantial toxicity, and were fairly bioavailable.

Conclusions

Results suggested that the compounds possess strong potential in developing putative lead compounds targeting HIF-1α that are safe natural plant-based drugs against breast cancer.


Corresponding author: Dr. Sukhes Mukherjee, Additional Professor, Department of Biochemistry, All India Institute of Medical Sciences (AIIMS) Bhopal, 3rd Floor, Medical College Building, AIIMS Bhopal, Saket Nagar, Bhopal 462020, India, E-mail:

Acknowledgments

The authors would like to thank Ms. Mansi Ravi and Ms. Shivani Mishra, M.Sc. students, Department of Biotechnology, Awadhesh Pratap Singh University, Rewa (M.P.) for their enthusiasm in helping us review the literature and support.

  1. Research ethics: This is not applicable since it is an in-silico study and no human subjects were involved.

  2. Informed consent: This is not applicable since it is an in-silico study and no human subjects were involved.

  3. Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  4. Competing interests: The authors state no conflict of interest.

  5. Research funding: Not applicable.

  6. Data availability: The raw data can be obtained on request from the corresponding author.

References

1. Arnold, M, Morgan, E, Rumgay, H, Mafra, A, Singh, D, Laversanne, M, et al.. Current and future burden of breast cancer: global statistics for 2020 and 2040. Breast 2022;66:15–23. https://doi.org/10.1016/j.breast.2022.08.010.Search in Google Scholar PubMed PubMed Central

2. Liu, Z, Semenza, GL, Zhang, H. Hypoxia-inducible factor 1 and breast cancer metastasis. J Zhejiang Univ – Sci B 2015;16:32–43. https://doi.org/10.1631/jzus.b1400221.Search in Google Scholar PubMed PubMed Central

3. Kozal, K, Krześlak, A. The role of hypoxia-inducible factor isoforms in breast cancer and perspectives on their inhibition in therapy. Cancers 2022;14:4518. https://doi.org/10.3390/cancers14184518.Search in Google Scholar PubMed PubMed Central

4. Liu, Q, Palmgren, VAC, Danen, EH, Le Dévédec, SE. Acute vs. chronic vs. intermittent hypoxia in breast cancer: a review on its application in in vitro research. Mol Biol Rep 2022;49:10961–73. https://doi.org/10.1007/s11033-022-07802-6.Search in Google Scholar PubMed PubMed Central

5. Muz, B, de la Puente, P, Azab, F, Azab, AK. The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy. Hypoxia 2015;3:83–92. https://doi.org/10.2147/hp.s93413.Search in Google Scholar PubMed PubMed Central

6. Al, TW, Dale, TP, Al-Jumaily, RMK, Forsyth, NR. Hypoxia-modified cancer cell metabolism. Front Cell Dev Biol 2019;7:4. https://doi.org/10.3389/fcell.2019.00004.Search in Google Scholar PubMed PubMed Central

7. Jun, JC, Rathore, A, Younas, H, Gilkes, D, Polotsky, VY. Hypoxia-inducible factors and cancer. Curr Sleep Med Rep 2017;3:1–10. https://doi.org/10.1007/s40675-017-0062-7.Search in Google Scholar PubMed PubMed Central

8. Soni, S, Padwad, YS. HIF-1 in cancer therapy: two decade long story of a transcription factor. Acta Oncol 2017;56:503–15. https://doi.org/10.1080/0284186x.2017.1301680.Search in Google Scholar PubMed

9. Xiong, Q, Liu, B, Ding, M, Zhou, J, Yang, C, Chen, Y. Hypoxia and cancer related pathology. Cancer Lett 2020;486:1–7. https://doi.org/10.1016/j.canlet.2020.05.002.Search in Google Scholar PubMed

10. Schito, L, Semenza, GL. Hypoxia-inducible factors: master regulators of cancer progression. Trends Cancer 2016;2:758–70. https://doi.org/10.1016/j.trecan.2016.10.016.Search in Google Scholar PubMed

11. de Heer, EC, Jalving, M, Harris, AL. HIFs, angiogenesis, and metabolism: elusive enemies in breast cancer. J Clin Invest 2020;130:5074–87. https://doi.org/10.1172/jci137552.Search in Google Scholar PubMed PubMed Central

12. Abou Khouzam, R, Brodaczewska, K, Filipiak, A, Zeinelabdin, NA, Buart, S, Szczylik, C, et al.. Tumor hypoxia regulates immune escape/invasion: influence on angiogenesis and potential impact of hypoxic biomarkers on cancer therapies. Front Immunol 2021;11:613114. https://doi.org/10.3389/fimmu.2020.613114.Search in Google Scholar PubMed PubMed Central

13. Sadlecki, P, Bodnar, M, Grabiec, M, Marszalek, A, Walentowicz, P, Sokup, A, et al.. The role of hypoxia-inducible factor-1α, glucose transporter-1, (GLUT-1) and carbon anhydrase IX in endometrial cancer patients. BioMed Res Int 2014;2014:1–11. https://doi.org/10.1155/2014/616850.Search in Google Scholar PubMed PubMed Central

14. Shin, E, Koo, JS. Glucose metabolism and glucose transporters in breast cancer. Front Cell Dev Biol 2021;9:728759. https://doi.org/10.3389/fcell.2021.728759.Search in Google Scholar PubMed PubMed Central

15. Xu, O, Li, X, Qu, Y, Liu, S, An, J, Wang, M, et al.. Regulation of glucose transporter protein-1 and vascular endothelial growth factor by hypoxia inducible factor 1α under hypoxic conditions in Hep-2 human cells. Mol Med Rep 2012;6:1418–22. https://doi.org/10.3892/mmr.2012.1075.Search in Google Scholar PubMed

16. Song, I-S, Wang, A-G, Yoon, SY, Kim, J-M, Kim, JH, Lee, D-S, et al.. Regulation of glucose metabolism-related genes and VEGF by HIF-1α and HIF-1β, but not HIF-2α, in gastric cancer. Exp Mol Med 2009;41:51. https://doi.org/10.3858/emm.2009.41.1.007.Search in Google Scholar PubMed PubMed Central

17. Walsh, JC, Lebedev, A, Aten, E, Madsen, K, Marciano, L, Kolb, HC. The clinical importance of assessing tumor hypoxia: relationship of tumor hypoxia to prognosis and therapeutic opportunities. Antioxid Redox Signal 2014;21:1516–54. https://doi.org/10.1089/ars.2013.5378.Search in Google Scholar PubMed PubMed Central

18. Rudzińska, A, Juchaniuk, P, Oberda, J, Wiśniewska, J, Wojdan, W, Szklener, K, et al.. Phytochemicals in cancer treatment and cancer prevention – review on epidemiological data and clinical trials. Nutrients 2023;15:1896. https://doi.org/10.3390/nu15081896.Search in Google Scholar PubMed PubMed Central

19. Abd Rani, NZ, Husain, K, Kumolosasi, E. Moringa genus: a review of phytochemistry and pharmacology. Front Pharmacol 2018;9:108. https://doi.org/10.3389/fphar.2018.00108.Search in Google Scholar PubMed PubMed Central

20. Kashyap, P, Kumar, S, Riar, CS, Jindal, N, Baniwal, P, Guiné, RPF, et al.. Recent advances in drumstick (Moringa oleifera) leaves bioactive compounds: composition, health benefits, bioaccessibility, and dietary applications. Antioxidants 2022;11:402. https://doi.org/10.3390/antiox11020402.Search in Google Scholar PubMed PubMed Central

21. Masarkar, N, Ray, SK, Saleem, Z, Mukherjee, S. Potential anti-cancer activity of Moringa oleifera derived bio-active compounds targeting hypoxia-inducible factor-1 alpha in breast cancer. J Compl Integr Med 2024;21:282–94. https://doi.org/10.1515/jcim-2023-0182.Search in Google Scholar PubMed

22. Morris, GM, Huey, R, Lindstrom, W, Sanner, MF, Belew, RK, Goodsell, DS, et al.. AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem 2009;30:2785–91. https://doi.org/10.1002/jcc.21256.Search in Google Scholar PubMed PubMed Central

23. Trott, O, Olson, AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 2009;31:455–61. https://doi.org/10.1002/jcc.21334.Search in Google Scholar PubMed PubMed Central

24. BIOVIA, Dassault Systems. Discovery studio visualizer 09. San Diego: Dassault Systems; 2020.Search in Google Scholar

25. Bhat, SS, Mahapatra, SD, R, S, Sommano, SR, Prasad, SK. Virtual screening and quantitative structure–activity relationship of Moringa oleifera with Melanoma Antigen A (MAGE-A) genes against the therapeutics of non-small cell lung cancers (NSCLCs). Cancers 2022;14:5052. https://doi.org/10.3390/cancers14205052.Search in Google Scholar PubMed PubMed Central

26. Mendie, LE, Hemalatha, S. Molecular docking of phytochemicals targeting GFRs as therapeutic sites for cancer: an in silico study. Appl Biochem Biotechnol 2022;194:215–31. https://doi.org/10.1007/s12010-021-03791-7.Search in Google Scholar PubMed PubMed Central

27. Ngbolua, J-PK-T-N, Kilembe, JT, Matondo, A, Ashande, CM, Mukiza, J, Nzanzu, CM, et al.. In silico studies on the interaction of four cytotoxic compounds with angiogenesis target protein HIF-1α and human androgen receptor and their ADMET properties. Bull Natl Res Cent 2022;46:1. https://doi.org/10.1186/s42269-022-00793-1.Search in Google Scholar

28. Aja, PM, Agu, PC, Ezeh, EM, Awoke, JN, Ogwoni, HA, Deusdedit, T, et al.. Prospect into therapeutic potentials of Moringa oleifera phytocompounds against cancer upsurge: de novo synthesis of test compounds, molecular docking, and ADMET studies. Bull Natl Res Cent 2021;45:1. https://doi.org/10.1186/s42269-021-00554-6.Search in Google Scholar

29. Han, Y, Zhang, J, Hu, CQ, Zhang, X, Ma, B, Zhang, P. In silico ADME and toxicity prediction of ceftazidime and its impurities. Front Pharmacol 2019;10:434. https://doi.org/10.3389/fphar.2019.00434.Search in Google Scholar PubMed PubMed Central

30. Baammi, S, El Allali, A, Daoud, R. Unleashing nature’s potential: a computational approach to discovering novel VEGFR-2 inhibitors from African natural compound using virtual screening, ADMET analysis, molecular dynamics, and MMPBSA calculations. Front Mol Biosci 2023;10:1227643. https://doi.org/10.3389/fmolb.2023.1227643.Search in Google Scholar PubMed PubMed Central

31. Iheagwam, FN, Ogunlana, OO, Ogunlana, OE, Isewon, I, Oyelade, J. Potential anti-cancer flavonoids isolated from Caesalpinia bonduc young twigs and leaves: molecular docking and in silico studies. Bioinf Biol Insights 2019;13:117793221882137. https://doi.org/10.1177/1177932218821371.Search in Google Scholar PubMed PubMed Central

32. Ajiboye, BO, Fatoki, TH, Akinnusi, PA, Ajuwon, OR, Oyinloye, BE, Jeje, TO, et al.. Molecular docking, MMGBSA, and ADMET studies of phytoconstituents of Ocimum gratissimum on multiple breast cancer targets. Nat Prod Res 2024:1–9. https://doi.org/10.1080/14786419.2024.2344193.Search in Google Scholar PubMed

33. Yousuf, Z, Iman, K, Iftikhar, N, Mirza, M. Structure-based virtual screening and molecular docking for the identification of potential multi-targeted inhibitors against breast cancer. Breast Cancer 2017;9:447–59. https://doi.org/10.2147/bctt.s132074.Search in Google Scholar

34. Bultum, LE, Tolossa, GB, Kim, G, Kwon, O, Lee, D. In silico activity and ADMET profiling of phytochemicals from Ethiopian indigenous aloes using pharmacophore models. Sci Rep 2022;12:22221. https://doi.org/10.1038/s41598-022-26446-x.Search in Google Scholar PubMed PubMed Central

35. Lamichhane, S, Rai, RP, Khatri, A, Adhikari, R, Shrestha, BG, Shrestha, SK. Screening of phytochemicals as potential anti-breast cancer agents targeting HER2: an in-silico approach. J Biomol Struct Dyn 2021;41:897–911. https://doi.org/10.1080/07391102.2021.2014972.Search in Google Scholar PubMed

36. Raju, L, Lipin, R, Eswaran, R. Identification, ADMET evaluation and molecular docking analysis of Phytosterols from Banaba (Lagerstroemia speciosa (L.)Pers) seed extract against breast cancer. Silico Pharmacol 2021;9:43. https://doi.org/10.1007/s40203-021-00104-y.Search in Google Scholar PubMed PubMed Central

37. Olaokun, OO, Zubair, MS. Antidiabetic activity, molecular docking, and ADMET properties of compounds isolated from bioactive ethyl acetate fraction of Ficus lutea leaf extract. Molecules 2023;28:7717. https://doi.org/10.3390/molecules28237717.Search in Google Scholar PubMed PubMed Central

38. Riyadi, PH, Romadhon, N, Sari, ID, Kurniasih, RA, Agustini, TW, Swastawati, F, et al.. SwissADME predictions of pharmacokinetics and drug-likeness properties of small molecules present in Spirulina platensis. IOP Conf Ser Earth Environ Sci 2021;890:012021. https://doi.org/10.1088/1755-1315/890/1/012021.Search in Google Scholar

39. Lipinski, CA, Lombardo, F, Dominy, BW, Feeney, PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1. Adv Drug Deliv Rev 2001;46:3–26. https://doi.org/10.1016/s0169-409x(00)00129-0.Search in Google Scholar PubMed

40. Ghose, AK, Viswanadhan, VN, Wendoloski, JJ. A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases. J Combin Chem 1998;1:55–68. https://doi.org/10.1021/cc9800071.Search in Google Scholar PubMed

41. Veber, DF, Johnson, SR, Cheng, H-Y, Smith, BR, Ward, KW, Kopple, KD. Molecular properties that influence the oral bioavailability of drug candidates. J Med Chem 2002;45:2615–23. https://doi.org/10.1021/jm020017n.Search in Google Scholar PubMed

42. Egan, WJ, Merz, KM, Baldwin, JJ. Prediction of drug absorption using multivariate statistics. J Med Chem 2000;43:3867–77. https://doi.org/10.1021/jm000292e.Search in Google Scholar PubMed

43. Muegge, I, Heald, SL, Brittelli, D. Simple selection criteria for drug-like chemical matter. J Med Chem 2001;44:1841–6. https://doi.org/10.1021/jm015507e.Search in Google Scholar PubMed

44. Daina, A, Michielin, O, Zoete, V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep 2017;7:42717. https://doi.org/10.1038/srep42717.Search in Google Scholar PubMed PubMed Central

45. Kombo, DC, Tallapragada, K, Jain, R, Chewning, J, Mazurov, AA, Speake, JD, et al.. 3D molecular descriptors important for clinical success. J Chem Inf Model 2013;53:327–42. https://doi.org/10.1021/ci300445e.Search in Google Scholar PubMed

46. St Jean, DJ, Fotsch, C. Mitigating heterocycle metabolism in drug discovery. J Med Chem 2012;55:6002–20. https://doi.org/10.1021/jm300343m.Search in Google Scholar PubMed

47. Xiong, G, Wu, Z, Yi, J, Fu, L, Yang, Z, Hsieh, C, et al.. ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties. Nucleic Acids Res 2021;49:W5–14. https://doi.org/10.1093/nar/gkab255.Search in Google Scholar PubMed PubMed Central

48. Bhal, SK, Kassam, K, Peirson, IG, Pearl, GM. The rule of five revisited: applying log D in place of log P in drug-likeness filters. Mol Pharm 2007;4:556–60. https://doi.org/10.1021/mp0700209.Search in Google Scholar PubMed

49. Sravika, N, Priya, S, Divya, N, Jyotsna, PMS, Anusha, P, Kudumula, N, et al.. Swiss ADME properties screening of the phytochemical compounds present in Bauhinia acuminata. J Pharmacogn Phytochem 2021;10:411–9. https://doi.org/10.22271/phyto.2021.v10.i4e.14193.Search in Google Scholar

50. El-Sayed, NNE, Almaneai, NM, Ben Bacha, A, El-Ashrey, MK, Al-Zaben, MI, Almarhoon, ZM. Biological evaluation, molecular docking analyses, and ADME profiling of certain new quinazolinones as anti-colorectal agents. ACS Omega 2022;7:18443–58. https://doi.org/10.1021/acsomega.2c00812.Search in Google Scholar PubMed PubMed Central

Received: 2024-05-26
Accepted: 2024-06-24
Published Online: 2024-07-22

© 2024 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Reviews
  3. Terpene-based novel invasomes: pioneering cancer treatment strategies in traditional medicine
  4. Mind-body practices for people living with dementia and their family carers: a systematic review
  5. Methodological advances in formulation and assay of herbal resources-based topical drug delivery systems
  6. Research Articles
  7. A potential therapeutic role of resveratrol in mitigating hepatotoxicity induced by paracetamol and alcohol
  8. A preclinical study on effect of betanin on sodium fluoride induced hepatorenal toxicity in Wistar rats
  9. Phytochemical characterization and evaluation of the biological activity spectrum of ethanolic fruit extract of Garcinia indica: a less explored plant of Ayurveda
  10. Scientific investigation on antibacterial, antioxidant, cytotoxic effects and TLC bioautography of Terminalia schimperiania stem bark extracts
  11. Albizia ferruginea (Guill. & Perr.) Benth. leaf abates deregulation of P53, IRS, HsD17β2, FTO, and CYP11a genes in polycystic ovarian syndrome rat
  12. Vernonia amygdalina aqueous leaf extract modulates metformin pharmacokinetics, inhibits CYP3A4 and CYP2C9 enzymes in streptozotocin-induced diabetic rats
  13. Quantitative determination of the antibacterial activity of licorice (Glycyrrhiza glabra) and tetracycline gel against Aggregatibacter actinomycetemcomitans (Aa), Porphyromonas gingivalis (Pg) and Prevotella intermedia (Pi) – a microbiological in vitro study
  14. In-silico screening of bioactive compounds of Moringa oleifera as potential inhibitors targeting HIF-1α/VEGF/GLUT-1 pathway against breast cancer
  15. Isolation, structural characterization, and molecular docking studies on the bioactive compound from n-Hexane extract of Emilia sonchifolia (L.) DC against the pancreatic cancer target Aurora 2 Kinase
  16. The impact of Omega-3 supplementation on arrhythmia reduction in acute coronary syndrome patients: a randomized clinical trial
  17. Evaluation of gastric tolerability for long-term use of diclofenac and celecoxib in male albino rats and potential gastroprotective benefits of royal jelly: a randomized controlled trial
  18. The efficacy of thread embedding acupuncture on pain score, neck disability index, and pressure pain threshold for myofascial pain therapy in the upper trapezius muscle
  19. Correction of hypoxic effects on target organs in pneumonia with phytotherapy
Downloaded on 9.11.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jcim-2024-0176/html
Scroll to top button
点击 这是indexloc提供的php浏览器服务,不要输入任何密码和下载